国产在线一区二区三区AV,国产AV天堂无码一区二区三区,黄色电影免费观看,国内精品久久久久久99蜜桃

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

四虎永久在线精品无码| 免费观看性欧美大片无片| 国产AV天堂无码一区二区三区| 亚洲色欲久久久久综合网| 色欲综合一区二区三区| 久久久久久精品天堂无码中文字幕| 久久丫精品国产亚洲AV不卡| 无码人妻AⅤ一区二区三区蜜桃 | 国产在线国偷精品免费看| 国色天香久久久久久久小说| 亚洲午夜精品久久久久久app| 免费看久久妇女高潮A| 97精品人人a片免费看| 免费播放一区二区三区| 日本天狼无码久久久久影院| 色婷婷国产精品视频一区二区| 亚洲一区自拍高清亚洲精品| 欧美成人熟妇激情视频人| 久久精品国产精品青草| 曰批视频免费40分钟试看| 日韩中文字幕区一区有砖一区| 人妻少妇精品无码专区漫画| 无码av天堂一区二区三区 | 免费a级毛片18禁网站app| 国产精品丝袜黑色高跟鞋| 欧美老妇牲交videos| 精品少妇高潮蜜臀涩涩AV| 欧美日韩在线播放二区| 农村熟妇高潮精品a片| 国产色欲AV精品一区二区| 久久大香香蕉国产| 久久无码人妻一区二区三区蜜桃| 国产人妻大战黑人20P| 晚秋影院手机在线观看免费| 99国产精品久久99久久久| 污污污污污污www网站免费| 国产在线精品成人一区二区三区| 亚洲精品国产精华液| 国产毛多水多做爰爽爽爽| 国产AV国片偷人妻麻豆| 狠狠综合久久AV一区二区三区|